Detail of "764667-65-4"

CAS Number:
764667-65-4
Name:
1,3-Butanedione,1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-
Superlist Name:
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
Molecular Structure:
Formula:
C₁₆H₁₂F₆N₄O₂
Molecular Weight:
406.28
Synonyms:
1,2,4-Triazolo[4,3-a]pyrazine,7-[1,3-dioxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-(9CI);4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one;7-[1,3-Dioxo-4-(2,4,5-trifluorophenyl)butyl]-3-trifluoromethyl-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine;
Density:
1.607 g/cm³
Boiling Point:
513.902 °C at 760 mmHg
Flash Point:
264.598 °C
Appearance:
brown oil

Display：

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity: All Rights Reserved. Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity. Thornberry, Nancy A.; Kaufman, Keith D. (USA ). U.S.There are some reagents with their cas registry numbers 847445-81-2 and 764667-65-4 are used in this study. Pat. Appl. Publ. US 2006270722 A1 30 Nov 2006,23pp. (English). (United States of America). CODEN: USXXCO. APPLICATION: US 2006-440198 24 May 2006. PRIORITY: US 2005-686076P 31 May 2005. DOCUMENT TYPE: Patent CA Section: 1 (Pharmacology) Section cross-reference(s): 28, 63 The present invention relates to pharmaceutical compns. comprising a combination of a particular dipeptidyl peptidase-IV (DPP-IV) inhibitor and a particular PPAR-a/g dual agonist, kits contg. such combinations and methods of using such compns. for the treatment of diabetes, diabetes assocd. with obesity, diabetes-related disorders, obesity, and obesity-related disorders. .